1.
Pembrolizumab-induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient.
Clin Case Rep
; 7(4): 773-775, 2019 Apr.
Article
in English
| MEDLINE
| ID: mdl-30997084
ABSTRACT
Pembrolizumab is an immune checkpoint inhibitor with antitumor activity in other organ malignancies. We present this case -demonstrating multiple inflammatory adverse events associated with Pembrolizumab (in a single patient), in order to increase awareness and facilitate earlier identification of the wide-ranging cutaneous side effects associated with immunotherapy.